MedScope Biotech Co., Ltd.

Have updates for this profile? Please contribute data

= Subscriber Access Only

You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.

With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.

MedScope Biotech Co., Ltd. - overview

Established

2017

Location

Taipei, -, Taiwan - China

Primary Industry

Medical Devices & Equipment

About

Founded in 2017 and based in Taiwan, MedScope Biotech Co. , Ltd. operates as a surgical devices supplier that is committed to the research, development, manufacturing, and sales of minimally invasive surgery (MIS) medical equipment. The company received ISO 13485 certification.


In November 2021, Daiwa PI Partners and AXR Group acquired the company. The company's main products include a 10mm vascular clamp, 5mm vascular clamp, puncture set, irrigator, Cadence irrigator, and automatic collection bag. The products are sold to Europe, Asia, Africa, Oceania, the Middle East, etc. The Cadence irrigator supports two types of grips which are pistol grip and trumpet grip.


The company's products can be used in minimally invasive surgeries and laparoscopic surgeries.


Current Investors

Daiwa PI Partners, AXR Group

Primary Industry

Medical Devices & Equipment

Sub Industries

Surgical Devices, Medical Supplies

Website

www.medscope.com.tw

Verticals

Manufacturing

Company Stage

Mature - Buyout

Total Amount Raised

Subscriber access only

MedScope Biotech Co., Ltd. - deals

Deals TypeDeal StatusTarget (s)Deal DateInvestor(s)Seller(s)Deal size (Mn)Enterprise value (Mn)Post-money valuation (Mn)EBITDA multiple (x)Revenue multiple (x)Lead partner (s)
BuyoutCompletedMedScope Biotech Co., Ltd.-

Displaying 1 - 1 of 1

Time to go Pro

Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.